Plain-English translation of NCT06523140 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our COPD research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a remote monitoring system called BoraCare that helps doctors catch COPD flare-ups before they become severe. You would wear a wristband that tracks your vital signs at home, and trained nurses would review your data daily to spot early warning signs. If warning signs appear, a nurse calls you and alerts your doctor so treatment can start quickly.
People with COPD who have had serious flare-ups needing hospitalization are at high risk for more flare-ups in the future. This trial wants to see if catching warning signs early at home—rather than waiting until symptoms are severe—can prevent hospitalizations and keep patients healthier.
You likely qualify if…
You likely don't qualify if…
If you join the monitoring group, you'll continue seeing your regular doctors as usual—your primary care doctor twice a year and your lung specialist once a year. Additionally, you'll wear a wristband at home that measures your heart rate, oxygen levels, and other vital signs, and trained nurses will check your data every day. When the system detects warning signs, a nurse will call you, and your lung doctor will decide if you need an urgent appointment, medicine adjustments, or other care. You'll follow up with your lung doctor again after 12 months.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
France